10x Genomics Inc.
Last updated September 27, 2026
Organization details
- Legal name
- 10x Genomics Inc.
- Ownership
- Public
- Status
- Active
- Headquarters country
- United States
- Ticker symbol
- TXG
- Primary stock exchange
- Nasdaq
Identifiers
- SEC CIK
- 0001770787
Board of directors
-
Alan Mateo · DirectorSince 2024
-
Benjamin J. Hindson · Director · See RemarksSince 2023
-
Bryan E. Roberts · DirectorSince 2023
-
John R. Stuelpnagel · DirectorSince 2023
-
Kimberly J. Popovits · DirectorSince 2023
-
Mathai Mammen · DirectorSince 2023
-
Sarah A. Teichmann · DirectorSince 2024
-
Serge Saxonov · Director · Chief Executive OfficerSince 2023
-
Shehnaaz Suliman · DirectorSince 2023
-
Sridhar Kosaraju · DirectorSince 2023
Chief executives
Serge Saxonov
· Chief Executive Officer
Dates unknown
Board connections
3 of this board's directors also sit on 5 other boards.
- via Kimberly J. Popovits
- via Kimberly J. Popovits
- via Mathai Mammen
- via Kimberly J. Popovits
- via Shehnaaz Suliman
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
- Bought, last 12 months
- $0
- 0 purchases by 0 insiders
- Sold, last 12 months
- $16,876,568
- 50 sales by 6 insiders
| Date | Insider | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Sep 22, 2026 | Serge Saxonov Director, Officer (Chief Executive Officer) | Open-market sale | −1,000 | $78.23 | $78,228 |
| Sep 22, 2026 | Shehnaaz Suliman Director | Open-market sale | −292 | $78.20 | $22,833 |
| Sep 22, 2026 | Serge Saxonov Director, Officer (Chief Executive Officer) | Open-market sale | −2,000 | $79.62 | $159,239 |
| Sep 22, 2026 | Shehnaaz Suliman Director | Open-market sale | −614 | $79.51 | $48,820 |
| Sep 22, 2026 | Serge Saxonov Director, Officer (Chief Executive Officer) | Open-market sale | −9,300 | $80.90 | $752,401 |
| Sep 22, 2026 | Shehnaaz Suliman Director | Open-market sale | −1,325 | $80.82 | $107,082 |
| Sep 22, 2026 | Serge Saxonov Director, Officer (Chief Executive Officer) | Open-market sale | −9,900 | $81.83 | $810,071 |
| Sep 22, 2026 | Shehnaaz Suliman Director | Open-market sale | −2,270 | $81.67 | $185,391 |
| Sep 22, 2026 | Serge Saxonov Director, Officer (Chief Executive Officer) | Open-market sale | −2,800 | $82.37 | $230,622 |
| Sep 22, 2026 | Shehnaaz Suliman Director | Open-market sale | −1,222 | $82.28 | $100,542 |
| Sep 9, 2026 | Taich Adam Officer (Chief Financial Officer) | Open-market sale | −1,206 | $63.68 | $76,795 |
| Sep 9, 2026 | Taich Adam Officer (Chief Financial Officer) | Open-market sale | −31,428 | $64.31 | $2,021,125 |
| Sep 9, 2026 | Taich Adam Officer (Chief Financial Officer) | Open-market sale | −13,754 | $65.26 | $897,550 |
| Sep 3, 2026 | John R. Stuelpnagel Director | Open-market sale | −7,012 | $60.66 | $425,333 |
| Sep 3, 2026 | John R. Stuelpnagel Director | Open-market sale | −6,814 | $62.11 | $423,205 |
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.